Company intelligence / Profile preview

PCL, Inc.

Seoul, South Korea

Ownership: Private
Employees: ~31
Development stage: Other

Overview

PCL, Inc. develops and manufactures in vitro diagnostic medical devices for immunological diagnosis using a multiplex diagnostic platform. Products include SolB™ Reagent, Hi3 series, Ci-5, and COVID-19 diagnostics exported to over 50 countries.

Industry: Protein Biomarker Diagnostics

Partnerships

Scienion AG (Germany)Orasure TechnologyLG ChemDong-A STSiemensAmerican Red Cross

Beyond the preview

Go deeper on PCL, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PCL, Inc..

Explore the full profile